- Investing Ideas
- /
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
82
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
82 companies
BioRestorative Therapies
Market Cap: US$11.1m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.47
7D
-10.6%
1Y
-3.9%
Active Biotech
Market Cap: SEK 257.1m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.21
7D
-5.0%
1Y
-57.8%
Quoin Pharmaceuticals
Market Cap: US$4.5m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$6.70
7D
-21.7%
1Y
-66.8%
Oryzon Genomics
Market Cap: €205.0m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€2.65
7D
-6.2%
1Y
46.3%
SynAct Pharma
Market Cap: SEK 1.1b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 22.10
7D
8.9%
1Y
142.9%
Diamyd Medical
Market Cap: SEK 1.5b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 10.88
7D
-4.7%
1Y
-41.6%
Rhythm Pharmaceuticals
Market Cap: US$5.6b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$85.23
7D
-2.3%
1Y
82.0%
Anavex Life Sciences
Market Cap: US$954.1m
Operates as a biopharmaceutical company.
AVXL
US$11.30
7D
-11.3%
1Y
71.7%
Egetis Therapeutics
Market Cap: SEK 2.0b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.51
7D
-9.7%
1Y
-6.1%
BioInvent International
Market Cap: SEK 2.6b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 38.90
7D
-3.6%
1Y
-4.1%
Beijing Wantai Biological Pharmacy Enterprise
Market Cap: CN¥74.1b
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
CN¥58.06
7D
-2.8%
1Y
-14.5%
BeOne Medicines
Market Cap: US$35.6b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$301.13
7D
1.6%
1Y
85.6%
Vertex Pharmaceuticals
Market Cap: US$120.5b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$456.87
7D
-3.3%
1Y
-9.7%
Unicycive Therapeutics
Market Cap: US$55.9m
A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.
UNCY
US$4.34
7D
-10.5%
1Y
1.7%
Everest Medicines
Market Cap: HK$20.2b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$62.10
7D
-11.3%
1Y
221.1%
Creative Medical Technology Holdings
Market Cap: US$7.1m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$2.78
7D
2.2%
1Y
-16.8%
Evaxion
Market Cap: US$17.5m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$2.68
7D
-1.1%
1Y
-81.3%
Amicus Therapeutics
Market Cap: US$1.9b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$5.99
7D
-4.6%
1Y
-41.3%
Day One Biopharmaceuticals
Market Cap: US$696.4m
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$6.71
7D
-6.9%
1Y
-52.6%
Mendus
Market Cap: SEK 468.8m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 9.00
7D
-10.0%
1Y
11.1%
CanSino Biologics
Market Cap: HK$15.8b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$43.75
7D
2.7%
1Y
134.7%
CStone Pharmaceuticals
Market Cap: HK$9.8b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$6.74
7D
-10.3%
1Y
426.6%
Japan Tissue Engineering
Market Cap: JP¥23.9b
Engages in the regenerative medicine business in Japan.
7774
JP¥588.00
7D
-4.5%
1Y
2.4%
Arctic Bioscience
Market Cap: NOK 99.4m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.
ABS
NOK 3.77
7D
5.0%
1Y
-65.4%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
Alector
Market Cap: US$160.0m
A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.
ALEC
US$1.49
7D
-16.8%
1Y
-74.0%
Aprea Therapeutics
Market Cap: US$10.2m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.70
7D
-11.9%
1Y
-54.1%
Arcturus Therapeutics Holdings
Market Cap: US$343.6m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$12.21
7D
-18.3%
1Y
-43.4%
Zai Lab
Market Cap: US$4.2b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$37.80
7D
1.7%
1Y
107.6%
Celcuity
Market Cap: US$1.6b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$39.17
7D
178.8%
1Y
118.3%
Geron
Market Cap: US$700.6m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.15
7D
-10.2%
1Y
-75.9%
GeoVax Labs
Market Cap: US$19.4m
A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.
GOVX
US$0.72
7D
-11.3%
1Y
-65.9%
Cutia Therapeutics
Market Cap: HK$2.7b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.52
7D
-7.3%
1Y
20.5%
PYC Therapeutics
Market Cap: AU$705.7m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.21
7D
-6.6%
1Y
24.7%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥30.1b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥113.70
7D
-2.4%
1Y
112.1%
TYK Medicines
Market Cap: HK$6.5b
A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.
2410
HK$17.42
7D
-11.9%
1Y
n/a